This was yet another great week at Designer Diagnostics. We continue to move forward with the 3rd party validation of our TB test kits and continue to build awareness of our products throughout the industry.
I’ll be sure to keep you posted with any important news and announcements. If you haven’t already, be sure to sign […]

Read Full Post »

We are happy to report that our research efforts are going well. As many of our shareholders know, ReceptoPharm’s main therapeutic focus is in the neurological (including pain) and antiviral areas.
Recent research highlights include:

Confirming the activity of RPI-78M in animal models of the autoimmune disease Multiple sclerosis, in addition to identifying novel target genes through […]

Read Full Post »